Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta …

T Cai, L Abel, O Langford, G Monaghan, JK Aronson… - Bmj, 2021 - bmj.com
Objective To assess the associations between statins and adverse events in primary
prevention of cardiovascular disease and to examine how the associations vary by type and …

Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients

SE Nissen, V Menon, SJ Nicholls, D Brennan, L Laffin… - Jama, 2023 - jamanetwork.com
Importance The effects of bempedoic acid on cardiovascular outcomes in statin-intolerant
patients without a prior cardiovascular event (primary prevention) have not been fully …

PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations

Q Hao, B Aertgeerts, G Guyatt, GE Bekkering… - Bmj, 2022 - bmj.com
Clinical question In adults with low density lipoprotein (LDL) cholesterol levels> 1.8 mmol/L
(> 70 mg/dL) who are already taking the maximum dose of statins or are intolerant to statins …

Redefining therapeutic success in HIV patients: an expert view

A Antela, A Rivero, JM Llibre… - Journal of Antimicrobial …, 2021 - academic.oup.com
Thanks to advances in the field over the years, HIV/AIDS has now become a manageable
chronic condition. Nevertheless, a new set of HIV-associated complications has emerged …

Assessment of sex disparities in nonacceptance of statin therapy and low-density lipoprotein cholesterol levels among patients at high cardiovascular risk

CJ Brown, LS Chang, N Hosomura… - JAMA Network …, 2023 - jamanetwork.com
Importance Many patients at high cardiovascular risk—women more commonly than men—
are not receiving statins. Anecdotally, it is common for patients to not accept statin therapy …

Long‐Term Effectiveness and Safety of Initiating Statin Therapy After Index Revascularization In Patients With Peripheral Arterial Occlusive Disease

F Peters, J Kuchenbecker, T Kreutzburg… - Journal of the …, 2020 - ahajournals.org
Background An increasing number of patients with a peripheral arterial occlusive disease
were put on statins during the past years. This study assessed whether statin therapy was …

Physician perspectives on statin continuation and discontinuation in older adults in primary cardiovascular prevention: a qualitative methods study

A Marti, S Zbinden, L Brunner, N Rodondi… - BMJ open, 2024 - bmjopen.bmj.com
Objectives In the context of limited evidence on statin use in primary cardiovascular
prevention in older adults, we assessed physician perspectives on decision-making about …

The effect of statins on mortality and cardiovascular disease in primary care hypertensive patients without other cardiovascular disease or diabetes

T Andersson, J Nåtman, G Mourtzinis… - European Journal of …, 2023 - academic.oup.com
Aims Studies in primary healthcare (PHC) assessing the effect of primary prevention with
statins on mortality and cardiovascular disease (CVD) are scarce. This study aimed to …

Association between low-density lipoprotein cholesterol and cardiovascular mortality in statin non-users: a prospective cohort study in 14.9 million Korean adults

SW Yi, SJ An, HB Park, JJ Yi… - International Journal of …, 2022 - academic.oup.com
Background Limited information is available on detailed sex/age-specific associations
between low-density lipoprotein cholesterol (LDL-C) and cardiovascular disease (CVD) …

[HTML][HTML] Barriers and facilitators to using statins: a qualitative study with patients and family physicians

S Butalia, RCW Lee-Krueger, KA McBrien, AAC Leung… - CJC open, 2020 - Elsevier
Background Despite their proven efficacy to reduce cardiovascular disease, statin
medication use remains low in individuals at high risk of cardiovascular disease considering …